Would you treat Dupuytren’s disease shortly after surgery or wait till the patient develops new contracture? What dose and fractionation do you use?
This question is part of our collaboration with ASTRO 2025 to highlight impactful trial data from this year's meeting. This question is inspired by the Clinical Trials Session Presentation "Toxicities and Quality of Life Following Observation or Radiation Therapy for Dupuytren's Disease in the International DEPART Randomized Trial" by Dr. Jarad Martin.